Annovis Bio schedules corporate update webinar for next week

·6d ago
Share:PostShare

26 August 2026 - Annovis Bio Inc (NYSE:ANVS), a Phase 3 clinical-stage biotechnology company developing an investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer�...

M

M2 Pharma

Original source

Read full story

next uk

Check live status on DownRightNow

Check status →

Related Stories

Brief
Science1h ago

A Data Center Backlash

Today we visit Pennsylvania, where there’s a high-stakes clash over A.I. jobs and the environment.

TThe New York Times

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer